Molecular mechanisms of melatonin's inhibitory actions on breast cancers

Print
Published on Wednesday, 11 December 2013

Abstract

Melatonin is involved in many physiological functions and it plays an important role in many pathological processes as well.

Melatonin has been shown to reduce the incidence of experimentally induced cancers and can significantly inhibit the growth of some human tumors, namely hormone-dependent cancers.

The anticancer effects of melatonin have been observed in breast cancer, both in in vivo with models of chemically induced rat mammary tumors, and in vitro studies on human breast cancer cell lines.

Melatonin acts at different physiological levels and its antitumoral properties are supported by a set of complex, different mechanisms of action, involving apoptosis activation, inhibition of proliferation, and cell differentiation.

 

NOTE: This publication cites (Ref. N. 56): L. Di Bella, M.T. Rossi, G. Scalera - Perspectives in pineal functions. Cattedra di Fisiologia Generale, Università di Modena, 41100 Modena (Italy).

 

 

About this publication.

 

See also About Melatonin.